Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Efficacy of Minimal Blistering Dose-Based Versus Conventional Excimer Laser Therapy for Vitiligo

In conclusion, MBD-based excimer laser irradiation achieved earlier repigmentation with fewer sessions compared with the conventional protocol without a statistically significant increase in cumulative irradiation dose.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors retrospectively compared two excimer laser dosing protocols for vitiligo in 43 patients at one hospital. The minimal blistering dose (MBD) group showed greater VASI improvement and reached VASI 50 earlier than the conventional half minimal erythema dose group, with mild, transient adverse events. The study was retrospective and single-center.

Participants
43
Who or what was studied
Patients with vitiligo who underwent more than 20 sessions of excimer laser therapy at Nagoya City University Hospital (29 conventional, 14 MBD).
Limits stated in the abstract
The study was retrospective, single-center, and included unequal, small group sizes.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Excimer laser therapy is an established treatment for vitiligo, but the optimal irradiation protocol remains unclear. Irradiation based on the minimal blistering dose (MBD) was recently proposed, but its efficacy relative to conventional protocols has not been systematically evaluated. In this study, we retrospectively analyzed 43 patients with vitiligo who underwent more than 20 sessions of excimer laser therapy at Nagoya City University Hospital, including 29 treated with the conventional protocol and 14 with the MBD protocol. In the conventional group, treatment was initiated at half the minimal erythema dose (MED) and gradually increased, whereas in the MBD group, treatment was initiated at twice the MED and maintained at the MBD, with further increases after photohardening. Treatment efficacy was assessed using the Vitiligo Area Scoring Index (VASI) at baseline, and after the 10th and 20th irradiation sessions. The MBD group showed significantly greater improvement in VASI (%) compared with the 1/2 MED group (p = 0.0041). The area under the curve (AUC₀-₂₀) for ΔVASI% over 20 sessions was also significantly higher in the MBD group (p < 0.0001). Furthermore, Kaplan-Meier analysis of time to VASI 50 achievement demonstrated that patients in the MBD group reached VASI 50 significantly earlier than those in the 1/2 MED group. Adverse events, including erythema, burning, and blistering, were mild and transient and resolved without treatment discontinuation. In conclusion, MBD-based excimer laser irradiation achieved earlier repigmentation with fewer sessions compared with the conventional protocol without a statistically significant increase in cumulative irradiation dose. This approach may reduce the treatment burden and accelerate clinical improvement in patients with vitiligo.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies